These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15987077)

  • 1. [Genetic variations in the metabolism of environmental toxins].
    Autrup H
    Ugeskr Laeger; 2005 May; 167(20):2173-6. PubMed ID: 15987077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic polymorphism and risk of diseases induced by chemicals].
    Zhang Z; Xia Z
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):402-5. PubMed ID: 14535113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
    Butkiewicz D; Chorazy M
    Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts.
    Thier R; Golka K; Brüning T; Ko Y; Bolt HM
    Toxicol Lett; 2002 Feb; 127(1-3):321-7. PubMed ID: 12052673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of studies of selected metabolic polymorphisms and cancer.
    d'Errico A; Malats N; Vineis P; Boffetta P
    IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
    Schulz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of toxic reactions to drugs and chemicals.
    Cascorbi I
    Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical toxins and body defences.
    Lappin G
    Biologist (London); 2002 Feb; 49(1):33-7. PubMed ID: 11852284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open questions on carcinogenesis of oral cancer: interaction between the environmental and genetic aspects.
    de Carvalho Ferreira D; da Rocha Curvelo JA; Passos MR
    Indian J Dent Res; 2009; 20(2):249. PubMed ID: 19553736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.
    Hatagima A
    Cad Saude Publica; 2002; 18(2):357-77. PubMed ID: 11923879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphism (sequence variation) of foreign substance-metabolizing enzymes and their significance in environmental medicine. Statement of the Commission "Methods and Quality Assurance in Environmental Medicine"].
    Commission on Methods and Quality Assurance in Environmental Medicine
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Nov; 47(11):1115-23. PubMed ID: 15549207
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
    Gresner P; Gromadzinska J; Wasowicz W
    Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism and their contribution to cancer susceptibility.
    Conforti-Froes N; el-Zein R; Au W
    Cad Saude Publica; 1998; 14 Suppl 3():7-13. PubMed ID: 9819460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prospect of application of toxicogenetics/pharmcogenetics theory and methods in forensic practice].
    Shen DN; Yi XF; Chen XG; Xu TL; Cui LJ
    Fa Yi Xue Za Zhi; 2007 Oct; 23(5):362-4. PubMed ID: 18175577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detoxification enzymes: cellular metabolism and susceptibility to various diseases.
    Silva M; Carvalho MDG
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):307-310. PubMed ID: 30133607
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of some genetic polymorphisms of cytochrome P-450 subfamilies CYP2D, CYP2E and CYP3A--part II].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2009 Aug; 27(158):166-9. PubMed ID: 19856888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
    Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.